Emily Day’s research group has published an invited perspective in ACS Nano that overviews nanoparticle-mediated photothermal therapy (PTT) and discusses recent insights into the mechanisms of cell death induced by this technique. PTT utilizes nanoparticles embedded within tumors to convert laser light energy into heat to ablate cancer cells. Depending on the laser irradiation conditions, PTT produces either necrosis or apoptosis, two distinct modes of cell death that impact therapy success differently. New information on the cellular signaling pathways involved in the PTT response provides researchers with a unique opportunity to enhance PTT’s successful elimination of cancer. Day recently received an ACCEL grant for breast cancer therapy using nanotechnology.
- Bio-inspired innovationsApril Kloxin has been inducted to the 2024 College of Fellows of the American Institute for Medical and Biological Engineering.
- Doctoral Dissertation Defense – Margo DonlinBME PhD Candidate Margo Donlin will be defending their dissertation: Adaptive Post-Stroke Gait Rehabilitation Methods To Increase Propulsion
- Doctoral Dissertation Defense – Michael DonzantiBME PhD Candidate Michael Donzanti will be defending their dissertation: A Multi-Faceted Approach for Addressing Poor Drug Transport Into the Lymph Node
- Kiick and Price labs awarded R01 from the National Institutes of HealthThanks to a five-year, $3 million research grant, a team of UD engineers will develop approaches to improve delivery of therapeutics to treat post-traumatic osteoarthritis.
- Orthopedics in actionUD Engineering’s Jenni Buckley develops orthopedics curriculum for high school students.